Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03391362 · ClinicalTrials.gov registry record · NA
Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases
A NA study of Small-cell Lung Cancer and Brain Metastases, sponsored by Dana-Farber Cancer Institute.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT03391362: Active NA study of Small-cell Lung Cancer and Brain Metastases, sponsored by Dana-Farber Cancer Institute.
NCT03391362 is a NA study of Small-cell Lung Cancer and Brain Metastases that is active but no longer recruiting, run by Dana-Farber Cancer Institute. The registered enrollment target is 100 participants, below the 231-participant average among 79 other Small-cell Lung Cancer trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03391362, a NA study of Small-cell Lung Cancer and Brain Metastases, is active but no longer recruiting, sponsored by Dana-Farber Cancer Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is studying stereotactic radiation (focused/pinpoint radiation that targets each individual tumor but not the surrounding brain) instead of whole-brain radiation (radiation targeting the entire brain) as a possible treatment for patients with small cell lung cancer and 1-10 brain metastases. The intervention involved in this study is: -Stereotactic (focused, pinpoint) radiation
Primary Outcome
Clinical parameter to be assessed via review of study visits and medical records indicating cause of death (neurologic versus systemic progressive disease).
Conditions Studied
Interventions
- RADIATION Stereotactic Radiation
Study Locations (1)
Massachusetts
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-02-23 |
| Est. Completion | 2026-02-01 |
| Phase | NA |
What the registry record for NCT03391362 still lists
NCT03391362 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 231-participant average among 79 other Small-cell Lung Cancer trials with a reported enrollment target (57% lower).
The record links to 2 conditions, with Small-cell Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Stereotactic Radiation is the first listed.
NCT03391362 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03391362 about?
NCT03391362 is a clinical study titled "Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases". This research study is studying stereotactic radiation (focused/pinpoint radiation that targets each individual tumor but not the surrounding brain) instead of whole-brain radiation (radiation targeting the entire brain) as a possible treatment for patients with small cell lung cancer and 1-10 brain...
What is the current status of trial NCT03391362?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2018-02-23. Estimated completion is 2026-02-01.
What conditions does trial NCT03391362 study?
This clinical trial studies the following conditions: Small-cell Lung Cancer, Brain Metastases.
What interventions are being tested in trial NCT03391362?
The interventions under investigation include: Stereotactic Radiation (RADIATION).
Who is sponsoring clinical trial NCT03391362?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03391362 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Small-cell Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03391362's enrollment target sits among peer trials
100 37th of 79 higher than 42 of 79 other Small-cell Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Small-cell Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Hospital-at-Home for People Receiving Tarlatamab
RECRUITING · NA
-
Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
RECRUITING · NA
-
LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)
RECRUITING · NA
-
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy
RECRUITING · NA
-
Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung Cancer
COMPLETED · NA
-
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI